Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| short-chain fatty acyl-CoA | CHEBI_61905 | [A fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of any short-chain fatty acid.] |
| 2-hydroxybutanoyl-CoA(4-) | CHEBI_138628 | [A short chain fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of 2-hydroxybutanoyl-CoA; major species at pH 7.3.] |
| 2-hydroxybutyric acid | CHEBI_1148 | [A hydroxybutyric acid having a single hydroxyl group located at position 2; urinary secretion of 2-hydroxybutyric acid is increased with alcohol ingestion or vigorous physical exercise and is associated with lactic acidosis and ketoacidosis in humans and diabetes in animals.] |
| 2-hydroxyhexanoyl-CoA | CHEBI_139304 | [A hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 2-hydroxyhexanoic acid.] |
| 2-hydroxyhexanoyl-CoA(4-) | CHEBI_138630 | [A medium chain fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of 2-hydroxyhexanoyl-CoA; major species at pH 7.3.] |
| 2-hydroxyhexanoic acid | CHEBI_86542 | [A hydroxy fatty acid that is caproic (hexanoic) acid substituted by a hydroxy group at position 2.] |
| 1-[(3S,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea | CHEBI_130978 | |
| otophylloside B | CHEBI_139305 | [A steroid saponin that is 17alpha-pregnenolone which is substituted by hydroxy groups at positions 8, 12beta, 14beta and 17beta, in which the 14beta-hydrocy group has been acylated by formal condensation with the carboxy group of (2E)-3,4-dimethylpent-2-enoic acid, and in which the hydroxy group at position 3 has been glycosylated with 2,6-dideoxy-3-O-methyl-beta-D-arabino-hexopyranosyl-(1->4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranos. A C-21 steroidal glycoside, it is the essential active ingredient of the traditional Chinese medicine Qingyangshen, isolated from Cynanchum otophyllum and used to treat epilepsy and rheumatic pain.] |
| 8-hydroxy steroid | CHEBI_139333 | [Any hydroxy steroid having a hydroxy group located at position 8.] |
| (3S)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-hydroxy-3-methylbut-1-ynyl)phenyl]-N-[(3R)-1-(phenylmethyl)-3-pyrrolidinyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide | CHEBI_130979 | |
| methanol extract of Sorbus alnifolia | CHEBI_139306 | [A mixture resulting from methanol extraction of dried stems and twigs of Sorbus alnifolia (Sieb. et Zucc.) K. Koch (Rosaceae) (also known as alder-leafed whitebeam, Korean whitebeam, or Korean mountain ash).] |
| alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-beta-D-GlcpNAcO[CH2]6CH=CH2 | CHEBI_139307 | [A glycoside formed between the branched tetrasaccharide alpha-L-Fuc-(1->2)-[alpha-D-GalNAc-(1->3)]-beta-D-Gal-(1->4)-beta-D-GlcNAc and the alkenyl alcohol oct-7-en-1-ol.] |
| alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-yl group | CHEBI_88110 | [A branched tetrasaccharide glucosaminyl group consisting of alpha-L-fucosyl, beta-D-galactosyl and N-acetyl-beta-D-D-glucosaminyl residues linked sequentially (1->2) and (1->4), to the galactosyl residue of which is also linked (1->3) an N-acetyl-beta-D-galactosaminyl residue. Blood group type-II A determinant.] |
| oct-7-en-1-ol | CHEBI_139284 | |
| alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->3)-alpha-D-GalpNAcO[CH2]6CH=CH2 | CHEBI_139308 | [A glycoside formed between the branched tetrasaccharide alpha-L-Fuc-(1->2)-[alpha-D-GalNAc-(1->3)]-beta-D-Gal-(1->3)-alpha-D-GalNAc and the alkenyl alcohol oct-7-en-1-ol.] |
| alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->3)-alpha-D-GalpNAc-yl group | CHEBI_88111 | [A branched tetrasaccharide glucosaminyl group consisting of alpha-L-fucosyl, beta-D-galactosyl and N-acetyl-alpha-D-D-galactosaminyl residues linked sequentially (1->2) and (1->3), to the galactosyl residue of which is also linked (1->3) an N-acetyl-beta-D-galactosaminyl residue. Blood group type-III A determinant.] |
| 1-[(1S)-2-acetyl-1-(hydroxymethyl)-7-methoxy-1'-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]yl]ethanone | CHEBI_130974 | |
| alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->3)-beta-D-GalpO[CH2]6CH=CH2 | CHEBI_139309 | [A glycoside formed between the branched tetrasaccharide alpha-L-Fuc-(1->2)-[alpha-D-GalNAc-(1->3)]-beta-D-Gal-(1->3)-beta-D-Gal and the alkenyl alcohol oct-7-en-1-ol.] |
| alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->3)-beta-D-Galp-yl group | CHEBI_139275 | [A branched tetrasaccharide galactosyl group consisting of alpha-L-fucosyl and two beta-D-galactosyl residues linked sequentially (1->2) and (1->3), to the non-reducing-end galactosyl residue of which is also linked (1->3) an N-acetyl-alpha-D-galactosyl residue. Blood group type-V A determinant.] |
| N-[(2R,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide | CHEBI_130975 |